ICCBBA convened the Forum 25 meeting in Lisbon, Portugal in September 2019, from which the Recommendations to Improve the Quality and Safety of Medical Products of Human Origin were created. The recommendations address traceability, patient safety, ethics, biovigilance and surveillance, and new technologies.
A total of 16 actions were identified from the discussions and feedback from health organizations, regulators, and professional societies. The recommendations also identify stakeholders who may be best to address the actions.
FACT is proud to endorse these recommendations, and is looking forward to seeing the results of these recommendations in the future. Any questions regarding the recommendations can be directed to email@example.com.